IOL Chemicals and Pharmaceuticals Ltd gets EDQM's CEP for API Clopidogrel Besilate

The European Directorate for the Quality of Medicines & Health Care (EDQM) has granted a Certificate of Suitability (CEP) for IOL Chemicals and Pharmaceuticals Limited's API product "CLOPIDOGREL BESILATE" on 23rd February 2026, in addition to the existing valid CEP already held by the Company for "CLOPIDOGREL BISULPHATE."

Clopidogrel is an antiplatelet medication used in the treatment and prevention of cardiovascular diseases.

Source : Equity Bulls

Keywords

IOLChemicalsandPharmaceuticals EDQM CEP ClopidogrelBesilate